Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01934361
Title Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA | ESP | CAN | BEL | AUS

Facility Status City State Zip Country Details
Barrow Neurological Insitute St. Joseph's Hospital Phoenix Arizona 85013 United States Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
MD Anderson Cancer Center/University of Texas Houston Texas 77030 United States Details
Novartis Investigative Site Heidelberg Victoria 3084 Australia Details
Novartis Investigative Site Parkville Victoria 3050 Australia Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 1Z6 Canada Details
Novartis Investigative Site Marseille Cedex 05 13885 France Details
Novartis Investigative Site Paris Cedex 13 75651 France Details
Novartis Investigative Site Saint Herblain cedex 44805 France Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field